Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic alteration of transplantable tissues through In Situ or Ex Vivo exposure to RNA interference molecules

Therapeutic alteration of transplantable tissues through In Situ or Ex Vivo exposure to RNA interference molecules

US Patent 12084660 · Granted Sep 10, 2024

Estimated economic value: $652,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting cell tropism receptors to inhibit cytomegalovirus infection2025
Methods for preventing graft ischemia reperfusion injury during ex vivo machine 2024
Methods for reducing risk of onset of acute graft versus host disease after hema2024
Targeting cell tropism receptors to inhibit cytomegalovirus infection2022
Therapeutic alteration of transplantable tissues through in situ or ex vivo expo2022
Therapeutic alteration of transplantable tissues through in situ or ex vivo expo2022
Therapeutic alteration of transplantable tissues through in situ or ex vivo expo2019
Therapeutic alteration of transplantable tissues through in situ or ex vivo expo2019
Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro2019
Methods of treating antibody-mediated rejection in organ transplant patients wit2018
Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro2017
Therapeutic alteration of transplantable tissues through in situ or ex vivo expo2015